THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,329 | -23.1% | 154 | -7.8% | 0.00% | – |
Q2 2023 | $1,728 | -10.0% | 167 | -5.6% | 0.00% | – |
Q1 2023 | $1,920 | -67.2% | 177 | -66.0% | 0.00% | – |
Q4 2022 | $5,846 | +16.9% | 521 | +15.8% | 0.00% | – |
Q3 2022 | $5,000 | +25.0% | 450 | +2.0% | 0.00% | – |
Q2 2022 | $4,000 | -20.0% | 441 | -10.7% | 0.00% | – |
Q1 2022 | $5,000 | +66.7% | 494 | +59.9% | 0.00% | – |
Q4 2021 | $3,000 | +200.0% | 309 | +99.4% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 155 | -3.1% | 0.00% | – |
Q2 2021 | $2,000 | -71.4% | 160 | -55.3% | 0.00% | – |
Q1 2021 | $7,000 | +600.0% | 358 | +336.6% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 82 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 82 | +39.0% | 0.00% | – |
Q2 2020 | $1,000 | -80.0% | 59 | -70.5% | 0.00% | -100.0% |
Q2 2018 | $5,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |